Non-tuberculous mycobacteria in children: Muddying the waters of tuberculosis diagnosis

The Lancet Respiratory Medicine

Volumn 3, Issue 3, 2015, Pages 244-256

  López Varela, Elisa ^a,b   García Basteiro, Alberto L ^a,b   Santiago, Begoña ^c   Wagner, Dirk ^d   van Ingen, Jakko ^e   Kampmann, Beate ^f,g  

^a Manhiça Health Research Center   (Mozambique)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF FREIBURG   (Germany)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Vaccinology Theme   (Gambia)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; CLARITHROMYCIN; ETHAMBUTOL; MACROLIDE; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT; BCG VACCINE;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BONE MARROW BIOPSY; BONE MARROW CULTURE; CELLULAR IMMUNITY; CERVICAL LYMPHADENOPATHY; CHILD HEALTH; CHRONIC ARTHRITIS; CHRONIC OSTEOMYELITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ENDEMIC DISEASE; GENETIC PREDISPOSITION; GEOGRAPHIC DISTRIBUTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG INFECTION; LUNG TUBERCULOSIS; LYMPHADENITIS; MIXED INFECTION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM HAEMOPHILUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM ULCERANS; NONHUMAN; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTION; TUBERCULIN TEST; ADOLESCENT; CHILD; COST OF ILLNESS; HEALTH; INFANT; ISOLATION AND PURIFICATION; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NEWBORN; PRESCHOOL CHILD; RISK FACTOR; SPUTUM;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DIAGNOSIS, DIFFERENTIAL; GLOBAL HEALTH; HOST-PATHOGEN INTERACTIONS; HUMANS; INFANT; INFANT, NEWBORN; LUNG DISEASES; LYMPHADENITIS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; RISK FACTORS; SPUTUM;

EID: 84924326122     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00062-4     Document Type: Review

References (149)

1. Blyth CC, Best EJ, Jones CA, et al. Nontuberculous mycobacterial infection in children: a prospective national study. Pediatr Infect Dis J 2009, 28:801-805.
2. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
3. Nolt D, Michaels MG, Wald ER Intrathoracic disease from nontuberculous mycobacteria in children: two cases and a review of the literature. Pediatrics 2003, 112:e434.
4. Cruz AT, Ong LT, Starke JR Mycobacterial infections in Texas children: a 5-year case series. Pediatr Infect Dis J 2010, 29:772-774.
5. Haverkamp MH, Arend SM, Lindeboom JA, Hartwig NG, van Dissel JT Nontuberculous mycobacterial infection in children: a 2-year prospective surveillance study in the Netherlands. Clin Infect Dis 2004, 39:450-456.
6. Pham-Huy A, Robinson JL, Tapiéro B, et al. Current trends in nontuberculous mycobacteria infections in Canadian children: a pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatr Child Health 2010, 15:276-282.
7. Shenai S, Rodrigues C, Mehta A Time to identify and define non-tuberculous mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis 2010, 14:1001-1008.
8. Hatherill M, Hawkridge T, Whitelaw A, et al. Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS One 2006, 1:e21.
9. Asiimwe BB, Bagyenzi GB, Ssengooba W, et al. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis 2013, 13:88.
10. Workalemahu B, Berg S, Tsegaye W, et al. Genotype diversity of Mycobacterium isolates from children in Jimma, Ethiopia. BMC Res Notes 2013, 6:352.
11. Farhat M, Greenaway C, Pai M, Menzies D False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 2006, 10:1192-1204.
12. Cobelens F False-positive tuberculin reactions due to non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 2007, 11:934-935.
13. Poyntz HC, Stylianou E, Griffiths KL, Marsay L, Checkley AM, McShane H Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb) 2014, 94:226-237.
14. Hoefsloot W, van Ingen J, Andrejak C, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: A NTM-NET collaborative study. Eur Respir J 2013, 42:1604-1613.
15. Marras TK, Daley CL Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002, 23:553-567.
16. Kendall BA, Winthrop KL Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med 2013, 34:87-94.
17. Marras TK, Chedore P, Ying AM, Jamieson F Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007, 62:661-666.
18. Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010, 182:970-976.
19. Ringshausen FC, Apel R-M, Bange F-C, et al. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011. BMC Infect Dis 2013, 13:231.
20. Brode SK, Daley CL, Marras TK The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis 2014, 18:1370-1377.
21. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Am J Respir Crit Care Med 1997, 156:S1-25. Medical Section of the American Lung Association.
22. Epson E, Cassidy M, Marshall-Olson A, Hedberg K, Winthrop KL Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease. Diagn Microbiol Infect Dis 2012, 74:98-100.
23. Romanus V, Hallander HO, Wåhlén P, Olinder-Nielsen AM, Magnusson PH, Juhlin I Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis 1995, 76:300-310.
24. Reuss AM, Wiese-Posselt M, Weissmann B, et al. Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J 2009, 28:642-644.
25. Katila ML, Brander E, Backman A Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. Tubercle 1987, 68:291-296.
26. Joshi W, Davidson PM, Jones PG, Campbell PE, Roberton DM Non-tuberculous mycobacterial lymphadenitis in children. Eur J Pediatr 1989, 148:751-754.
27. Sigalet D, Lees G, Fanning A Atypical tuberculosis in the pediatric patient: implications for the pediatric surgeon. J Pediatr Surg 1992, 27:1381-1384.
28. Grange JM, Yates MD, Pozniak A Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. Arch Dis Child 1995, 72:516-517.
29. Wolinsky E Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995, 20:954-963.
30. Lindeboom JA, Kuijper EJ, Bruijnesteijn van Coppenraet ES, Lindeboom R, Prins JM Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. Clin Infect Dis 2007, 44:1057-1064.
31. Pokam BT, Asuquo AE Acid-fast bacilli other than mycobacteria in tuberculosis patients receiving directly observed therapy short course in cross river state, Nigeria. Tuberc Res Treat 2012, 2012:301056.
32. Maiga M, Siddiqui S, Diallo S, et al. Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis. PLoS One 2012, 7:e36902.
33. Falkinham JO Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996, 9:177-215.
34. Falkinham JO Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis 2011, 17:419-424.
35. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci USA 2009, 106:16393-16399.
36. Iroh Tam P-Y, Kline S, Wagner JE, et al. Rapidly growing mycobacteria among pediatric hematopoietic cell transplant patients traced to the hospital water supply. Pediatr Infect Dis J 2014, 33:1043-1046.
37. Kline S, Cameron S, Streifel A, et al. An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 2004, 25:1042-1049.
38. Kankya C, Muwonge A, Djønne B, et al. Isolation of non-tuberculous mycobacteria from pastoral ecosystems of Uganda: public health significance. BMC Public Health 2011, 11:320.
39. Buijtels PCAM, van der Sande MAB, Parkinson S, Verbrugh HA, Petit PLC, van Soolingen D Isolation of non-tuberculous mycobacteria at three rural settings in Zambia; a pilot study. Clin Microbiol Infect 2010, 16:1142-1148.
40. De Groote MA, Pace NR, Fulton K, Falkinham JO Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils. Appl Environ Microbiol 2006, 72:7602-7606.
41. Maekawa K, Ito Y, Hirai T, et al. Environmental risk factors for pulmonary Mycobacterium avium-intracellulare complex disease. Chest 2011, 140:723-729.
42. Aitken ML, Limaye A, Pottinger P, et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. Am J Respir Crit Care Med 2012, 185:231-232.
43. Ricketts WM, O'Shaughnessy TC, van Ingen J Human-to-human transmission of Mycobacterium kansasii or victims of a shared source?. Eur Respir J 2014, 44:1085-1087.
44. Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013, 381:1551-1560.
45. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA 2006, 296:292-300.
46. Horsburgh CR Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991, 324:1332-1338.
47. Alarcón JO, Freimanis-Hance L, Krauss M, et al. Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States. AIDS Res Hum Retroviruses 2012, 28:282-288.
48. Levine B, Chaisson RE Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection. Ann Intern Med 1991, 114:861-868.
49. Reilly AF, McGowan KL Atypical mycobacterial infections in children with cancer. Pediatr Blood Cancer 2004, 43:698-702.
50. Levendoglu-Tugal O, Munoz J, Brudnicki A, Fevzi Ozkaynak M, Sandoval C, Jayabose S Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 1998, 27:1227-1230.
51. Nicholson O, Feja K, LaRussa P, et al. Nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplant recipients: case report and review of the literature. Pediatr Infect Dis J 2006, 25:263-267.
52. Unal E, Yen C, Saiman L, et al. A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2006, 12:1188-1197.
53. Morales P, Gil A, Santos M Mycobacterium abscessus infection in transplant recipients. Transplant Proc 2010, 42:3058-3060.
54. Jordan N, Waghmare A, Abi-Ghanem AS, Moon A, Salvatore CM Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2012, 54:294-296.
55. Mirsaeidi M, Hadid W, Ericsoussi B, Rodgers D, Sadikot RT Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis 2013, 17:e1000-e1004.
56. Zar HJ Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol 2008, 43:1-10.
57. Amorosa JK, Miller RW, Laraya-Cuasay L, et al. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Pediatr Radiol 1992, 22:603-606.
58. Bustamante J, Picard C, Boisson-Dupuis S, Abel L, Casanova J-L Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Ann N Y Acad Sci 2011, 1246:92-101.
59. Van de Vosse E, Hoeve MA, Ottenhoff THM Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004, 4:739-749.
60. Kampmann B, Hemingway C, Stephens A, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest 2005, 115:2480-2488.
61. Lawn SD, Myer L, Edwards D, Bekker L-G, Wood R Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009, 23:1717-1725.
62. Latorre I, De Souza-Galvão M, Ruiz-Manzano J, et al. Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J 2010, 35:338-342.
63. Kampmann B, Whittaker E, Williams A, et al. Interferon-γ release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009, 33:1374-1382.
64. van Ingen J, de Zwaan R, Dekhuijzen R, Boeree M, van Soolingen D Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 2009, 191:5865-5867.
65. Penn R, Steehler MK, Sokohl A, Harley EH Nontuberculous mycobacterial cervicofacial lymphadenitis-a review and proposed classification system. Int J Pediatr Otorhinolaryngol 2011, 75:1599-1603.
66. Staufner C, Sommerburg O, Holland-Cunz S Algorithm for early diagnosis in nontuberculous mycobacterial lymphadenitis. Acta Paediatr 2012, 101:e382-e385.
67. Hermansen TS, Thomsen VØ, Lillebaek T, Ravn P Non-tuberculous mycobacteria and the performance of interferon γ release assays in Denmark. PLoS One 2014, 9:e93986.
68. Magdorf K, Schuck SD, Leitner S, Wahn U, Kaufmann SHE, Jacobsen M T-cell responses against tuberculin and sensitin in children with tuberculosis and non-tuberculosis mycobacterial lymphadenopathy. Clin Microbiol Infect 2008, 14:1079-1083.
69. Rodrigues LC, Diwan VK, Wheeler JG Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993, 22:1154-1158.
70. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271:698-702.
71. Roy A, Eisenhut M, Harris RJ, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ 2014, 349:g4643.
72. Weir RE, Black GF, Nazareth B, et al. The influence of previous exposure to environmental mycobacteria on the interferon-γ response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol 2006, 146:390-399.
73. Trial of BCG vaccines in south India for tuberculosis prevention: first report. Bull World Health Organ 1979, 57:819-827. Tuberculosis Prevention Trial.
74. Burl S, Adetifa UJ, Cox M, et al. The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One 2010, 5:e12287.
75. Orme IM, Roberts AR, Collins FM Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria. Tubercle 1986, 67:41-46.
76. Thom M, Howard C, Villarreal-Ramos B, Mead E, Vordermeier M, Hope J Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Tuberculosis (Edinb) 2008, 88:324-334.
77. Lee WJ, Kang SM, Sung H, et al. Non-tuberculous mycobacterial infections of the skin: a retrospective study of 29 cases. J Dermatol 2010, 37:965-972.
78. Correa AG, Starke JR Nontuberculous mycobacterial disease in children. Semin Respir Infect 1996, 11:262-271.
79. Edeer Karaca N, Boisson-Dupuis S, Aksu G, et al. Granulomatous skin lesions, severe scrotal and lower limb edema due to mycobacterial infections in a child with complete IFN-γ receptor-1 deficiency. Immunotherapy 2012, 4:1121-1127.
80. Lindeboom JA, Bruijnesteijn van Coppenraet LES, van Soolingen D, Prins JM, Kuijper EJ Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections. Clin Microbiol Rev 2011, 24:701-717.
81. Williams B, Neth O, Shingadia D, et al. Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child. Pediatr Infect Dis J 2010, 29:88-89.
82. Powell DA, Walker DH Nontuberculous mycobacterial endobronchitis in children. J Pediatr 1980, 96:268-270.
83. Dore ND, LeSouëf PN, Masters B, et al. Atypical mycobacterial pulmonary disease and bronchial obstruction in HIV-negative children. Pediatr Pulmonol 1998, 26:380-388.
84. Osorio A, Kessler RM, Guruprasad H, Isaacson G Isolated intrathoracic presentation of Mycobacterium avium complex in an immunocompetent child. Pediatr Radiol 2001, 31:848-851.
85. Freeman AF, Olivier KN, Rubio TT, et al. Intrathoracic nontuberculous mycobacterial infections in otherwise healthy children. Pediatr Pulmonol 2009, 44:1051-1056.
86. Ferrara E, Lemire J, Grimm PC, et al. Mycobacterial peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 2004, 19:114-117.
87. Song Y, Wu J, Yan H, Chen J Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 2012, 27:1639-1644.
88. Hatzenbuehler LA, Starke JR Common presentations of nontuberculous mycobacterial infections. Pediatr Infect Dis J 2014, 33:89-91.
89. Kim YK, Hahn S, Uh Y, et al. Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases. Int J Tuberc Lung Dis 2014, 18:725-729.
90. Koh WJ, Yu CM, Suh GY, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 2006, 10:1001-1007.
91. Kendall BA, Varley CD, Hedberg K, Cassidy PM, Winthrop KL Isolation of non-tuberculous mycobacteria from the sputum of patients with active tuberculosis. Int J Tuberc Lung Dis 2010, 14:654-656.
92. Olivier KN, Weber DJ, Wallace RJ, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003, 167:828-834.
93. Roux A-L, Catherinot E, Ripoll F, et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol 2009, 47:4124-4128.
94. Leung JM, Olivier KN Nontuberculous mycobacteria in patients with cystic fibrosis. Semin Respir Crit Care Med 2013, 34:124-134.
95. Esther CR, Henry MM, Molina PL, Leigh MW Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005, 40:39-44.
96. Leung JM, Olivier KN Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med 2013, 19:662-669.
97. Seddon P, Fidler K, Raman S, et al. Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009. Emerg Infect Dis 2013, 19:1128-1130.
98. Martiniano SL, Sontag MK, Daley CL, Nick JA, Sagel SD Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 2014, 11:36-44.
99. De Beaucoudrey L, Samarina A, Bustamante J, et al. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010, 89:381-402.
100. Hoshina T, Takada H, Sasaki-Mihara Y, et al. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan. J Clin Immunol 2011, 31:309-314.
101. Haverkamp MH, van de Vosse E, van Dissel JT Nontuberculous mycobacterial infections in children with inborn errors of the immune system. J Infect 2014, 68(suppl 1):S134-S150.
102. Shachor-Meyouhas Y, Sprecher H, Eluk O, Ben-Barak A, Kassis I An outbreak of Mycobacterium mucogenicum bacteremia in pediatric hematology-oncology patients. Pediatr Infect Dis J 2011, 30:30-32.
103. Arlotta A, Cefalo MG, Maurizi P, Ruggiero A, Dodi I, Riccardi R Critical pulmonary infection due to nontuberculous mycobacterium in pediatric leukemia: report of a difficult diagnosis and review of pediatric series. J Pediatr Hematol Oncol 2014, 36:66-70.
104. Kornreich L, Goshen Y, Horev G, Grunebaum M Mycobacterial respiratory infection in leukemic children. Eur J Radiol 1995, 21:44-46.
105. Lawn SD, Lipman MC, Easterbrook PJ Immune reconstitution disease associated with mycobacterial infections. Curr Opin HIV AIDS 2008, 3:425-431.
106. Steenhoff AP, Wood SM, Shah SS, Rutstein RM Cutaneous Mycobacterium avium complex infection as a manifestation of the immune reconstitution syndrome in a human immunodeficiency virus-infected child. Pediatr Infect Dis J 2007, 26:755-757.
107. Orikiiriza J, Bakeera-Kitaka S, Musiime V, Mworozi EA, Mugyenyi P, Boulware DR The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS 2010, 24:2009-2017.
108. Giampaglia CMS, Martins MC, Inumaru VTG, Butuem IV, Telles MAS Evaluation of a rapid differentiation test for the MycobacteriuM tuberculosis complex by selective inhibition with rho-nitrobenzoic acid and thiophene-2-carboxylic acid hydrazide. Int J Tuberc Lung Dis 2005, 9:206-209.
109. Martin A, Bombeeck D, Mulders W, Fissette K, De Rijk P, Palomino JC Evaluation of the TB Ag MPT64 Rapid test for the identification of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis 2011, 15:703-705.
110. van Ingen J, Boeree MJ, van Soolingen D, Mouton JW Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012, 15:149-161.
111. Bruijnesteijn van Coppenraet ES, Lindeboom JA, Prins JM, Peeters MF, Claas ECJ, Kuijper EJ Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol 2004, 42:2644-2650.
112. Danielides V, Patrikakos G, Moerman M, Bonte K, Dhooge C, Vermeersch H Diagnosis, management and surgical treatment of non-tuberculous mycobacterial head and neck infection in children. ORL J Otorhinolaryngol Relat Spec 2014, 64:284-289.
113. Bruijnesteijn van Coppenraet LES, Kuijper EJ, Lindeboom JA, Prins JM, Claas ECJ Mycobacterium haemophilum and lymphadenitis in children. Emerg Infect Dis 2005, 11:62-68.
114. Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996, 9:435-447.
115. Kilby JM, Marques MB, Jaye DL, Tabereaux PB, Reddy VB, Waites KB The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med 1998, 104:123-128.
116. Akpek G, Lee SM, Gagnon DR, Cooley TP, Wright DG Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol 2001, 67:100-106.
117. Ker C-C, Hung C-C, Huang S-Y, et al. Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2002, 35:89-93.
118. Prego V, Glatt AE, Roy V, Thelmo W, Dincsoy H, Raufman JP Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients. Arch Intern Med 1990, 150:333-336.
119. Cappell MS, Schwartz MS, Biempica L Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus. Am J Med 1990, 88:123-130.
120. Crump JA, Tanner DC, Mirrett S, McKnight CM, Reller LB Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia. J Clin Microbiol 2003, 41:1987-1990.
121. Morgan MB, Reves RR, Wilson ML, Stone BL, Burman WJ Comparison of BACTEC 12B vs solid media for the recovery of Mycobacterium avium complex from blood cultures in AIDS patients. Diagn Microbiol Infect Dis 1997, 28:45-48.
122. Alfa MJ, Manickam K, Sepehri S, Sitter D, Lenton P Evaluation of BacT/Alert 3D automated unit for detection of nontuberculous mycobacteria requiring incubation at 30 degrees C for optimal growth. J Clin Microbiol 2011, 49:2691-2693.
123. Kordy F, Richardson SE, Stephens D, Lam R, Jamieson F, Kitai I Utility of gastric aspirates for diagnosing tuberculosis in children in a low prevalence area: predictors of positive cultures and significance of non-tuberculous mycobacteria. Pediatr Infect Dis J 2014, published online Aug 6. 10.1097/INF.0000000000000498.
124. Oberhelman RA, Soto-Castellares G, Gilman RH, et al. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis 2010, 10:612-620.
125. Sanchini A, Fiebig L, Drobniewski F, et al. Laboratory diagnosis of paediatric tuberculosis in the European Union/European Economic Area: analysis of routine laboratory data, 2007 to 2011. Euro Surveill 2014, 19:20744.
126. Peres RL, Maciel EL, Morais CG, et al. Comparison of two concentrations of NALC-NaOH for decontamination of sputum for mycobacterial culture. Int J Tuberc Lung Dis 2009, 13:1572-1575.
127. Bange F-C, Böttger EC Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2002, 21:546-548.
128. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004, 42:2321-2325.
129. Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999, 160:15-21.
130. Buijtels PC, van der Sande M, de Graaff CS, et al. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis 2009, 15:242-249.
131. Al Jarad N, Demertzis P, Jones DJ, et al. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax 1996, 51:137-139.
132. Daley CL, Griffith DE Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 2010, 14:665-671.
133. van Ingen J, Kuijper EJ Drug susceptibility testing of nontuberculous mycobacteria. Future Microbiol 2014, 9:1095-1110.
134. van Ingen J, Egelund EF, Levin A, et al. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. Am J Respir Crit Care Med 2012, 186:559-565.
135. Koh W-J, Jeong B-H, Jeon K, Lee S-Y, Shin SJ Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012, 186:797-802.
136. Zeharia A, Eidlitz-Markus T, Haimi-Cohen Y, Samra Z, Kaufman L, Amir J Management of nontuberculous mycobacteria-induced cervical lymphadenitis with observation alone. Pediatr Infect Dis J 2008, 27:920-922.
137. Lindeboom JA Conservative wait-and-see therapy versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children. Clin Infect Dis 2011, 52:180-184.
138. Perdikogianni C, Galanakis E Non-tuberculous mycobacterial cervical lymphadenitis in the immunocompetent child: diagnostic and treatment approach. Expert Rev Anti Infect Ther 2014, 12:959-965.
139. Parker NP, Scott AR, Finkelstein M, et al. Predicting surgical outcomes in pediatric cervicofacial nontuberculous mycobacterial lymphadenitis. Ann Otol Rhinol Laryngol 2012, 121:478-484.
140. Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hurst GA Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983, 128:1048-1050.
141. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996, 335:377-383. for the Canadian HIV Trials Network Protocol 010 Study Group.
142. Karakousis PC, Moore RD, Chaisson RE Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 2004, 4:557-565.
143. Siberry GK, Abzug MJ, Nachman S, et al. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J 2013, 32(suppl 2):i-KK4.
144. Mofenson LM, Brady MT, Danner SP, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009, 58:1-166.
145. Holland SM Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection. Microbes Infect 2000, 2:1579-1590.
146. Chantrain CF, Bruwier A, Brichard B, et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-γ receptor 1 deficiency. Bone Marrow Transplant 2006, 38:75-76.
147. Roesler J, Horwitz ME, Picard C, et al. Hematopoietic stem cell transplantation for complete IFN-γ receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004, 145:806-812.
148. Sester M, van Leth F, Bruchfeld J, et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med 2014, 190:1168-1176.
149. Basu Roy R, Sotgiu G, Altet-Gómez N, et al. Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin? A pTB-NET collaborative study. Am J Respir Crit Care Med 2012, 186:378-384.